Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Total segment depreciation and amortization

Other segment segments

Oncology & Multispecialty
$66M—
North American Pharmaceutical
$39M—
Prescription Technology Solutions
$19M-9.5%

Similar metrics at other companies

Ferguson Enterprises logo
FERGCanada Segment — Total depreciation and amortization
$5M+25.0%
Finance of America Companies logo
FOARetirement Solutions — Amortization and depreciation
$9.41M+0.9%
Ferguson Enterprises logo
FERGUnited States Segment — Total depreciation and amortization
$92M+3.4%
Equifax logo
EFXWorkforce Solutions — Depreciation and amortization expenses
$49.6M+10.7%
Novanta logo
NOVTMedical Solutions — Intangible Amortization
$3.71M-18.0%
Sonida Senior Living logo
SNDAReportable Segment — Depreciation and amortization expense
$19.96M+45.8%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%—
Debt / equity2×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)Three Months Ended June 30, 2026Three Months Ended June 30, 2025
North American Pharmaceutical$39$32
Oncology & Multispecialty6642
Prescription Technology Solutions1921
Medical-Surgical Solutions2622
Other—3
Corporate4537
Total segment depreciation and amortization$195$157
Segment expenditures for long-lived assets (8)

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's medical-surgical solutions — total segment depreciation and amortization?
McKesson (MCK) reported medical-surgical solutions — total segment depreciation and amortization of $26M in Q2 2026.
How has McKesson's medical-surgical solutions — total segment depreciation and amortization changed year-over-year?
McKesson's medical-surgical solutions — total segment depreciation and amortization increased by 18.2% year-over-year, from $22M to $26M.
What is the long-term trend for McKesson's medical-surgical solutions — total segment depreciation and amortization?
Over 4 years (2022 to 2026), McKesson's medical-surgical solutions — total segment depreciation and amortization has grown at a -7.1% compound annual growth rate (CAGR), from $129M to $96M.
What does medical-surgical solutions — total segment depreciation and amortization mean?
The total non-cash expense related to the depreciation of physical assets and the amortization of intangible assets within the Medical-Surgical Solutions segment. This metric reflects the ongoing cost of maintaining the segment's capital infrastructure and acquired intellectual property. It is essential for calculating the segment's true cash-generating capability.

Ask your AI about McKesson's medical-surgical solutions — total segment depreciation and amortization.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude